Summary
- Current Price
- As of today, RGNX price is $9.69, down -4.25% on
- Current Price All-Time High
- RGNX price is currently -88.61% below its historical high of $85.10 set on
- Market Cap
- RGNX current market cap is $620M, up +44.67% over the past 365 days
- Revenue
- RGNX current annual revenue is $170.44M, up +104.54% year-over-year
- Next Earnings
- The next earnings release for RGNX is on
Profile
| Metric | Value |
|---|---|
| Full Name | REGENXBIO Inc. |
| Ticker | NASDAQ: RGNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | regenxbio.com |
| Employees | 353 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.69 | |
| Price, 1D Change | -4.25% | |
| $620M | ||
| - | ||
| - | ||
| 2.10 | ||
| $170M | ||
| Revenue, 1Y Change | +104.54% | |
| -$3.76 | ||
| EPS, 1Y Change | +18.05% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.76 | ||
| EPS Estimate | N/A | -$2.79 |
| EPS Est. Change | N/A | +25.75% |
| $170.44M | ||
| Revenue Estimate | N/A | $237.89M |
| Revenue Est. Change | N/A | +39.57% |
| Current Price | $9.69 | |
| Price Target | - | $19.00 |
| Price Tgt. Change | - | +96.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.76 | -$4.59 | +3.59% | |
| -$3.30 | -$3.76 | -14.02% | |
| -$2.79 | N/A | +25.75% | |
| -$2.54 | N/A | +32.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $87.11M | $83.33M | -4.34% | |
| $185.98M | $170.44M | -8.36% | |
| $237.89M | N/A | +39.57% | |
| $247.51M | N/A | +45.22% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.69 | |
| $10.57 | ||
| $9.46 | ||
| $9.89 | ||
| $10.11 | ||
| -$0.22 | ||
| 2.10 | ||
| $0.93 | ||
| 42.78 | ||
| 51.01% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $170.44M | ||
| -$3.76 | ||
| $150.14M | ||
| 88.09% | ||
| -$161.20M | ||
| -94.58% | ||
| -$193.88M | ||
| -113.75% | ||
| -$145.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.54 | ||
| 2.38 | ||
| 2.38 | ||
| - | ||
| 1 | ||
| -2.78 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.06 | ||
| 29.43 | ||
| -2.98 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $102.73M | ||
| $230.07M | ||
| $453.03M | ||
| $281.28M | ||
| $350.30M | ||
| $118.10M | ||
| $260.52M | ||
| $47.90M | ||
| $21.36M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $364.32M | ||
| $311.34M | ||
| $20.30M | ||
| $0.00 | ||
| $15.62M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$123.96M | ||
| -$15.87M | ||
| $116.77M | ||
| $2.41M | ||
| -$126.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| Baird | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RGNX
FAQ
- What is the ticker symbol for REGENXBIO Inc.?
- The ticker symbol for REGENXBIO Inc. is NASDAQ:RGNX
- Does REGENXBIO Inc. pay dividends?
- No, REGENXBIO Inc. does not pay dividends
- What sector is REGENXBIO Inc. in?
- REGENXBIO Inc. is in the Healthcare sector
- What industry is REGENXBIO Inc. in?
- REGENXBIO Inc. is in the Biotechnology industry
- What country is REGENXBIO Inc. based in?
- REGENXBIO Inc. is headquartered in United States
- When did REGENXBIO Inc. go public?
- REGENXBIO Inc. initial public offering (IPO) was on September 17, 2015
- Is REGENXBIO Inc. in the S&P 500?
- No, REGENXBIO Inc. is not included in the S&P 500 index
- Is REGENXBIO Inc. in the NASDAQ 100?
- No, REGENXBIO Inc. is not included in the NASDAQ 100 index
- Is REGENXBIO Inc. in the Dow Jones?
- No, REGENXBIO Inc. is not included in the Dow Jones index
- When was REGENXBIO Inc. last earnings report?
- REGENXBIO Inc.'s most recent earnings report was on May 14, 2026
- When does REGENXBIO Inc. report earnings?
- The next expected earnings date for REGENXBIO Inc. is August 6, 2026
Data Sources & References
- RGNX Official Website www.regenxbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590877/000119312526094013/0001193125-26-094013-index.htm
- RGNX Profile on Yahoo Finance finance.yahoo.com/quote/RGNX
- RGNX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgnx